Other OTC - Delayed Quote USD

Bayer Aktiengesellschaft (BAYZF)

28.21 +0.28 (+0.99%)
At close: 3:45 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. William N. Anderson Chairman of the Management Board & CEO 8.99M -- 1966
Mr. Wolfgang U. Nickl CFO & Member of Management Board 2.11M -- 1969
Mr. Heiko W. J. Schipper Member of Management Board & President of the Consumer Health Division 2.08M -- 1969
Mr. Stefan Oelrich Head of the Pharmaceuticals Division & Member of the Board of Management 2.08M -- 1968
Mr. Rodrigo Santos Member of Management Board & President of the Crop Science Division 2.31M -- 1973
Ms. Heike Prinz Chief Talent Officer, Labor Director & Member of Management Board 1.42M -- 1964
Mr. Julio Triana Member of Management Board & President of Consumer Health Division -- -- 1966
Dr. Sebastian Guth Ph.D. Chief Operating Officer -- -- --
Dr. Jost Reinhard Head of Investor Relations -- -- 1972
Mr. Michael Preuss Head of Communications, Government Relations and Corporate Brand -- -- --

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen, 51368
Germany
49 214 30 1 https://www.bayer.com
Sector: 
Healthcare
Full Time Employees: 
96,931

Description

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Corporate Governance

Bayer Aktiengesellschaft’s ISS Governance QualityScore as of April 1, 2024 is 3. The pillar scores are Audit: 10; Board: 2; Shareholder Rights: 1; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Related Tickers